BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynolds IS, McNamara DA, Kay EW, O'Neill B, Deasy J, Burke JP. The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Surg Oncol. 2018;118:1129-1134. [PMID: 30261095 DOI: 10.1002/jso.25247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 O'Connell E, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Resistance to Cell Death in Mucinous Colorectal Cancer-A Review. Cancers (Basel) 2021;13:1389. [PMID: 33808549 DOI: 10.3390/cancers13061389] [Reference Citation Analysis]
2 Nagtegaal ID, Glynne-Jones R. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat Rev 2020;84:101964. [PMID: 32000055 DOI: 10.1016/j.ctrv.2020.101964] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
3 Li Z, Li S, Zang S, Ma X, Chen F, Xia Y, Chen L, Shen F, Lu Y, Lu J. Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Mucinous Adenocarcinoma Using an MRI-Based Radiomics Nomogram. Front Oncol 2021;11:671636. [PMID: 34109121 DOI: 10.3389/fonc.2021.671636] [Reference Citation Analysis]
4 Reynolds IS, O'Connell E, Fichtner M, Kay EW, McNamara DA, Prehn JHM, Burke JP. Mucin Pools Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Marker of Response or Epiphenomenon? Am J Surg Pathol 2020;44:280-7. [PMID: 31567193 DOI: 10.1097/PAS.0000000000001373] [Reference Citation Analysis]
5 Zhan TC, Zhang DK, Gu J, Li M. Surgical complications after different therapeutic approaches for locally advanced rectal cancer. World J Gastrointest Oncol 2019; 11(5): 393-403 [PMID: 31139309 DOI: 10.4251/wjgo.v11.i5.393] [Reference Citation Analysis]